
Sign up to save your podcasts
Or


Effective perioperative pain management has shifted from an opioid-centric, reactive model to a proactive, patient-centered approach focused on Multimodal Analgesia (MMA) and preventive care. The primary goal is to provide adequate pain relief while minimizing opioid consumption, accelerating functional recovery, and preventing the transition of acute pain into chronic post-surgical pain (CPSP).
Multimodal and Preventive Analgesia MMA involves combining different classes of medications—such as acetaminophen, NSAIDs, gabapentinoids, NMDA antagonists (e.g., ketamine), and alpha-2 agonists (e.g., dexmedetomidine)—with local and regional anesthesia. This synergistic approach significantly reduces opioid requirements, thereby lowering the risk of adverse effects like respiratory depression, nausea, and addiction. Additionally, preventive analgesia—initiating pain control before surgical trauma and continuing it throughout the perioperative period—helps block nociceptive input and limits central nervous system sensitization (or "wind-up"), which is a key driver of CPSP.
Tailoring Care to Specific Populations
Non-Pharmacological Interventions & Prehabilitation Non-pharmacological therapies are vital adjuncts to traditional analgesia. Modalities such as patient education, cognitive behavioral therapy, music therapy, massage, and aromatherapy effectively alleviate preoperative anxiety and lower postoperative pain scores. Furthermore, prehabilitation—a structured physical, nutritional, and psychological optimization program completed before surgery—builds a patient's physiological reserve, cutting recovery times and reducing post-surgical complications.
By integrating MMA, personalized risk assessments, and non-pharmacological strategies, clinicians can deliver superior pain control, reduce the global reliance on opioids, and significantly improve surgical outcomes.
By Stackx StudiosEffective perioperative pain management has shifted from an opioid-centric, reactive model to a proactive, patient-centered approach focused on Multimodal Analgesia (MMA) and preventive care. The primary goal is to provide adequate pain relief while minimizing opioid consumption, accelerating functional recovery, and preventing the transition of acute pain into chronic post-surgical pain (CPSP).
Multimodal and Preventive Analgesia MMA involves combining different classes of medications—such as acetaminophen, NSAIDs, gabapentinoids, NMDA antagonists (e.g., ketamine), and alpha-2 agonists (e.g., dexmedetomidine)—with local and regional anesthesia. This synergistic approach significantly reduces opioid requirements, thereby lowering the risk of adverse effects like respiratory depression, nausea, and addiction. Additionally, preventive analgesia—initiating pain control before surgical trauma and continuing it throughout the perioperative period—helps block nociceptive input and limits central nervous system sensitization (or "wind-up"), which is a key driver of CPSP.
Tailoring Care to Specific Populations
Non-Pharmacological Interventions & Prehabilitation Non-pharmacological therapies are vital adjuncts to traditional analgesia. Modalities such as patient education, cognitive behavioral therapy, music therapy, massage, and aromatherapy effectively alleviate preoperative anxiety and lower postoperative pain scores. Furthermore, prehabilitation—a structured physical, nutritional, and psychological optimization program completed before surgery—builds a patient's physiological reserve, cutting recovery times and reducing post-surgical complications.
By integrating MMA, personalized risk assessments, and non-pharmacological strategies, clinicians can deliver superior pain control, reduce the global reliance on opioids, and significantly improve surgical outcomes.